Avingtrans (AVG) AI Stock Analysis

• Market Cap: £118.30M
• Dividend Yield: 1.31%
• Average Volume (3M): 23.75K
• Price to Earnings (P/E): 27.4
• Beta (1Y): 0.19
• Revenue Growth: 14.30%
• EPS Growth: -25.58%
• Country: UK
• Employees: 941
• Sector: Industrials
• Sector Strength: 72
• Industry: Industrial Goods
• EPS (TTM): 0.13
• Shares Outstanding: 33,089,924
• 10 Day Avg. Volume: 35,387
• 30 Day Avg. Volume: 23,753
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.79
• Price to Cash Flow (P/CF): 12.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

Avingtrans shows strong revenue growth and operational efficiency, but faces profitability challenges and cash flow issues. Despite a high P/E ratio and moderate dividend yield suggesting valuation concerns, recent corporate events signal strategic progress and potential for future growth. Technical indicators reflect a cautious market stance, with a neutral to bearish sentiment. Overall, the stock presents a balanced risk-reward scenario with significant focus needed on improving cash flow and managing leverage.

Avingtrans Business Overview & Revenue Model

Company Description

Avingtrans (AVG) is a diversified engineering company that designs, manufactures, and supplies critical components, systems, and services for markets including energy, medical, and industrial sectors. The company operates across multiple segments, focusing on precision engineering and technical support to deliver high-quality, innovative solutions tailored to meet specific industry needs.

How the Company Makes Money

Avingtrans makes money through the sale of its engineered products and services across its core sectors. The company generates revenue from manufacturing and supplying precision components for the energy and medical markets, such as MRI-compatible products and high-integrity systems for the oil and gas industry. Additionally, Avingtrans offers repair, maintenance, and technical support services, which provide steady income. Key revenue streams include long-term contracts, direct sales to industries, and strategic partnerships with major clients in the energy and healthcare sectors. These factors, combined with a focus on innovation and quality, contribute significantly to its earnings.

Avingtrans Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement		Total Revenue
136.62M	116.44M	99.08M	98.52M	91.96M
	Gross Profit
44.04M	36.86M	32.59M	28.38M	22.21M
	EBIT
5.64M	8.24M	6.89M	7.18M	1.19M
	EBITDA
12.65M	13.20M	12.02M	11.03M	6.95M
	Net Income Common Stockholders
3.66M	5.19M	6.48M	3.99M	1.39M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
12.12M	17.72M	24.29M	30.08M	5.09M
	Total Assets
186.34M	155.41M	154.69M	142.61M	131.23M
	Total Debt
23.96M	8.58M	10.96M	9.80M	21.43M
	Net Debt
11.84M	-9.14M	-13.33M	-20.27M	16.35M
	Total Liabilities
73.33M	46.96M	48.88M	43.65M	61.33M
	Stockholders Equity
110.44M	106.04M	103.82M	97.30M	69.91M
Cash Flow		Free Cash Flow
-11.06M	985.00K	-1.10M	4.03M	-4.76M
	Operating Cash Flow
1.33M	9.68M	3.88M	6.45M	-13.00K
	Investing Cash Flow
-13.58M	-12.63M	-9.52M	24.56M	-4.02M
	Financing Cash Flow
6.78M	-3.40M	-371.00K	-5.85M	713.00K

Avingtrans Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 357.50
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:AVG, the sentiment is Neutral. The current price of 357.5 is above the 20-day moving average (MA) of 357.03, below the 50-day MA of 367.62, and below the 200-day MA of 383.88, indicating a neutral trend. The MACD of -3.10 indicates Negative momentum. The RSI at 48.17 is Neutral, neither overbought nor oversold. The STOCH value of 56.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:AVG.

Avingtrans Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RNO	70 Outperform	£84.68M	5.45	27.26%	1.28%	-6.48%	―
GLE	68 Neutral	£271.65M	16.51	5.65%	2.35%	13.91%	-2.75%
AVG	66 Neutral	£118.30M	27.37	3.87%	1.31%	14.30%	-25.58%
OXIG	65 Neutral	$1.07B	21.06	14.23%	1.10%	7.18%	-13.14%
Sector *	62 Neutral	$8.16B	12.85	0.64%	3.04%	3.83%	-15.83%

Avingtrans Corporate Events

Avingtrans Reports Strong Interim Results with Significant Revenue Growth

Avingtrans PLC reported a strong financial performance for the six months ending November 30, 2024, with a 21.2% increase in group revenue to £79.0m and an 18.7% rise in adjusted EBITDA to £8.7m. The Advanced Engineering Systems division drove this growth, benefiting from global energy demand and infrastructure expansion. The Medical and Industrial Imaging division also showed progress, with initial sales of Adaptix products and expansion plans for Magnetica. The company remains optimistic about meeting its full-year targets, supported by a robust order book and strategic investments in key divisions.

Avingtrans Secures £4.5m HS2 Contract, Strengthening Market Position

Avingtrans PLC’s subsidiary, Booth Industries, has secured a significant £4.5 million contract to supply pressure-rated fire doors for the HS2 project, building on a previous £36 million contract for cross passage doors. This development highlights Booth’s innovative expertise in creating industry benchmark safety products with global market potential, reinforcing its position in the sector by providing crucial infrastructure for high-speed railways.

Avingtrans PLC Reports Steady Trading and Growth Prospects

Avingtrans PLC reported that its trading for the first half of the financial year was in line with expectations, with strong performances in its Advanced Engineering Systems division and increased traction in its Medical products distribution in the US and Europe. The company’s position in the market is bolstered by successful endurance testing of HS2 tunnel doors, setting the stage for future contracts, and a solid order book driven by favorable conditions in the energy, infrastructure, and healthcare sectors, indicating continued growth potential.